APLN and melanoma: Studying the circulating apelin levels, we found that the plasma levels of apelin were significantly elevated in patients with melanoma (vs. healthy controls, 1.4590 ± 0.2676 ng/ml vs. 0.7704 ± 0.7117 ng/ml, respectively, p = 0.0011; Fig. 5A).